ANDREW SERAFIN

SVP Business Development & Corporate Strategy

 

Mr. Serafin is responsible for leading Harmony’s business development and long-term corporate strategy efforts, including the expansion of the company’s pipeline through the acquisition and licensing of novel rare disease therapies for patients with high unmet needs.

Mr. Serafin has 18 years of experience in mergers & acquisitions and corporate legal counseling in the pharmaceutical, broader healthcare, and technology sectors. Mr. Serafin previously served as Vice President of Business Development at Marathon Pharmaceuticals, LLC, Vice President of M&A and General Counsel at AltaThera Pharmaceuticals, and Vice President of U.S. Legal Affairs and Associate General Counsel at Lundbeck Inc., where he oversaw and executed on transactions with valuations of up to $1 billion.

Mr. Serafin began his career in private legal practice where he specialized in corporate transactions, provided strategic consulting, and consummated both public and private deals, including acquisitions, divestitures, and collaborations.

He holds a B.S. from the University of Illinois, a J.D. from the Loyola University Chicago School of Law, and an M.B.A. from the Northwestern University Kellogg School of Management.